This paradigm shift was supported by Medzhitov and colleagues, demonstrating that microbiota-derived signals via the toll-like receptor (TLR)-related adaptor protein MyD88 protect mice from the development of colitis (28) and intestinal tumor formation (29). Here, MYD88 is linked to colitis.